Login/Sign Up
Bdparp 150 Tablet is used to treat various cancers, including ovarian, breast, pancreatic, and prostate. It contains Olaparib, a targeted drug called a PARP inhibitor. PARP is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage. Avoid taking this medication if you are pregnant or breastfeeding because this can cause harmful effects on the unborn baby. Both women and men using this should use birth control to avoid pregnancy.
₹44280*
MRP ₹54000
18% off
₹45900*
MRP ₹54000
15% CB
₹8100 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Selected Pack Size:56
(₹790.71 per unit)
In Stock
(₹790.71 per unit)
In Stock
Whats That
About Bdparp 150 Tablet
Bdparp 150 Tablet is an 'anti-cancer' drug used to treat various cancers, including ovarian, breast, pancreatic, and prostate. Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissue, including organs.
Bdparp 150 Tablet contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
Use this medicine as directed by your doctor. You may sometimes experience shortness of breath (dyspnoea), feeling very tired, pale skin or fast heartbeat, anaemia, feeling sick (nausea), being sick (vomiting), indigestion or heartburn (dyspepsia), loss of appetite, headache, changes in taste of foods (dysgeusia), feeling dizzy, cough and diarrhoea. Most of these side effects may gradually resolve over time. However, if the side effects persist or worsen, consult your doctor.
To treat your condition effectually, continue taking Bdparp 150 Tablet for as long as your doctor has prescribed. Do not stop using the Bdparp 150 Tablet midway. Talk to your doctor before taking Bdparp 150 Tablet if you have severe allergic reactions to Bdparp 150 Tablet or other medicines or suffer from severe infections, renal dysfunction, hepatic disorders and blood cell counts are too low. Avoid taking Bdparp 150 Tablet if you are pregnant or breastfeeding because this Bdparp 150 Tablet can cause harmful effects on the unborn baby. Both women and men using this Bdparp 150 Tablet should use birth control to avoid pregnancy. While on Bdparp 150 Tablet treatment, you should avoid eating grapefruit, Seville oranges or consuming grapefruit juice since it can affect how the medicine works.
Uses of Bdparp 150 Tablet
Medicinal Benefits
Bdparp 150 Tablet belongs to a group of medicines known as 'anti-cancer' drugs used to treat various cancers, including Ovarian, breast, pancreatic, and prostate. Bdparp 150 Tablet contains Olaparib, a targeted drug called a PARP inhibitor. PARP (polyadenosine 5’-diphosphoribose polymerase) is a protein that helps damaged cells repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
Side Effects of Bdparp 150 Tablet
Directions for Use
Storage
Drug Warnings
Always take this medicine exactly as your doctor or healthcare professional has told you. To treat your condition effectually, continue taking Bdparp 150 Tablet for as long as your doctor has prescribed. Do not stop Bdparp 150 Tablet midway. Talk to your doctor before taking Bdparp 150 Tablet if you have severe allergic reactions to Bdparp 150 Tablet or other medicines or suffer from any medical illness. Avoid taking Bdparp 150 Tablet if you are pregnant or breastfeeding because this Bdparp 150 Tablet can cause harmful effects on the unborn baby. Both women and men using this Bdparp 150 Tablet should use birth control to avoid pregnancy. Do not start Bdparp 150 Tablet unless patients have recovered from haematological damage induced by previous chemotherapy (Grade 1). Check full blood count for cytopenia at baseline and monthly afterwards for clinically significant changes during treatment. For persistent haematological toxicity, discontinue Bdparp 150 Tablet and monitor blood count weekly until recovery. Do not receive any immunization or vaccination without your doctor's approval while taking the Bdparp 150 Tablet .
Therapeutic Class
Drug-Drug Interactions
Drug-Food Interactions
Diet & Lifestyle Advise
Habit Forming
How Bdparp 150 Tablet Works
What if I have taken an overdose of Bdparp 150 Tablet
Alcohol
Caution
Avoid alcohol consumption while on treatment with Bdparp 150 Tablet .
Pregnancy
Unsafe
Bdparp 150 Tablet should not be used during pregnancy because it can harm your fetus (newborn baby). Both women of childbearing potential and men must use an effective contraception method while taking Bdparp 150 Tablet and at least for six months later treatment. Your doctor will weigh the benefits and risks before prescribing this medicine.
Breast Feeding
Unsafe
Do not breastfeed during this treatment because the medicine may pass into your milk. Doctors normally advise against breastfeeding throughout this treatment and for one month after the final medication is taken.
Driving
Caution
Bdparp 150 Tablet may affect your reactions and your ability to drive. Do not drive and/or operate machines that require your alertness.
Liver
Caution
In patients with mild or moderate liver impairment, there is no need to alter the initial dose. There is no information available on patients with severe liver impairment.
Kidney
Caution
In patients with mild or moderate kidney impairment, there is no need to alter the initial dose. There is no information available on patients with severe kidney impairment.
Children
Caution
The safety and effectiveness of Bdparp 150 Tablet in pediatric patients have not been established.
Country of origin
Manufacturer/Marketer address
Product Substitutes